115 related articles for article (PubMed ID: 6490793)
1. Vertebral body bone mineral content in hyperprolactinemic women.
Koppelman MC; Kurtz DW; Morrish KA; Bou E; Susser JK; Shapiro JR; Loriaux DL
J Clin Endocrinol Metab; 1984 Dec; 59(6):1050-3. PubMed ID: 6490793
[TBL] [Abstract][Full Text] [Related]
2. Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea.
Schlechte J; el-Khoury G; Kathol M; Walkner L
J Clin Endocrinol Metab; 1987 May; 64(5):1021-6. PubMed ID: 3558723
[TBL] [Abstract][Full Text] [Related]
3. Bone density in amenorrheic women with and without hyperprolactinemia.
Schlechte JA; Sherman B; Martin R
J Clin Endocrinol Metab; 1983 Jun; 56(6):1120-3. PubMed ID: 6404918
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
Schlechte J; Walkner L; Kathol M
J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
[TBL] [Abstract][Full Text] [Related]
5. Effects of prolactin and estrogen deficiency in amenorrheic bone loss.
Klibanski A; Biller BM; Rosenthal DI; Schoenfeld DA; Saxe V
J Clin Endocrinol Metab; 1988 Jul; 67(1):124-30. PubMed ID: 3379129
[TBL] [Abstract][Full Text] [Related]
6. Decreased spinal mineral content in amenorrheic women.
Cann CE; Martin MC; Genant HK; Jaffe RB
JAMA; 1984 Feb; 251(5):626-9. PubMed ID: 6690836
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of bone turnover and bone mineral density in hyperprolactinemic amenorrheic women.
Shaarawy M; El-Dawakhly AS; Mosaad M; El-Sadek MM
Clin Chem Lab Med; 1999 Apr; 37(4):433-8. PubMed ID: 10369115
[TBL] [Abstract][Full Text] [Related]
8. Increase in bone mass after treatment of hyperprolactinemic amenorrhea.
Klibanski A; Greenspan SL
N Engl J Med; 1986 Aug; 315(9):542-6. PubMed ID: 3736637
[TBL] [Abstract][Full Text] [Related]
9. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea.
Biller BM; Baum HB; Rosenthal DI; Saxe VC; Charpie PM; Klibanski A
J Clin Endocrinol Metab; 1992 Sep; 75(3):692-7. PubMed ID: 1517356
[TBL] [Abstract][Full Text] [Related]
10. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia.
Orwoll ES; Meier DE
J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418
[TBL] [Abstract][Full Text] [Related]
11. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL
Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189
[TBL] [Abstract][Full Text] [Related]
12. The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women.
Nordin BE; Robertson A; Seamark RF; Bridges A; Philcox JC; Need AG; Horowitz M; Morris HA; Deam S
J Clin Endocrinol Metab; 1985 Apr; 60(4):651-7. PubMed ID: 3156144
[TBL] [Abstract][Full Text] [Related]
13. Comparison of vertebral and peripheral mineral losses in disuse osteoporosis in monkeys.
Cann CE; Genant HK; Young DR
Radiology; 1980 Feb; 134(2):525-9. PubMed ID: 6766220
[TBL] [Abstract][Full Text] [Related]
14. Increased vertebral bone mineral in response to reduced exercise in amenorrheic runners.
Lindberg JS; Powell MR; Hunt MM; Ducey DE; Wade CE
West J Med; 1987 Jan; 146(1):39-42. PubMed ID: 3825107
[TBL] [Abstract][Full Text] [Related]
15. Decreased bone mineral status in lactating adolescent mothers.
Chan GM; Ronald N; Slater P; Hollis J; Thomas MR
J Pediatr; 1982 Nov; 101(5):767-70. PubMed ID: 6982323
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa.
Biller BM; Saxe V; Herzog DB; Rosenthal DI; Holzman S; Klibanski A
J Clin Endocrinol Metab; 1989 Mar; 68(3):548-54. PubMed ID: 2493036
[TBL] [Abstract][Full Text] [Related]
17. Single and dual energy tomographic analysis of spinal trabecular bone: a comparative study in normal and osteoporotic women.
Pacifici R; Susman N; Carr PL; Birge SJ; Avioli LV
J Clin Endocrinol Metab; 1987 Feb; 64(2):209-14. PubMed ID: 3491831
[TBL] [Abstract][Full Text] [Related]
18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
19. Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia.
Caraceni MP; Corghi E; Ortolani S; Casazza S; D'Alberton A; Motta T
Calcif Tissue Int; 1985 Dec; 37(6):687-9. PubMed ID: 3937596
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral content of amenorrheic and eumenorrheic athletes.
Drinkwater BL; Nilson K; Chesnut CH; Bremner WJ; Shainholtz S; Southworth MB
N Engl J Med; 1984 Aug; 311(5):277-81. PubMed ID: 6738640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
